Menarini Silicon Biosystems announces publication of the DETECT III trial results highlighting the potential clinical utility of HER2 testing in circulating tumor cells with CELLSEARCH

Menarini Silicon Biosystems United Kingdom United States of America Canada Germany Spain France

View original content:https://www.prnewswire.co.uk/news-releases/menarini-silicon-biosystems-announces-publication-of-the-detect-iii-trial-results-highlighting-the-potential-clinical-utility-of-her2-testing-in-circulating-tumor-cells-with-cellsearch-302029601.html